Trends in clinical trials reports in common cancers between 1989 and 2000

Journal of Clinical Oncology

Volumn 21, Issue 9, 2003, Pages 1850-1858

  Hillner, Bruce E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER; CANCER PREVENTION; CANCER SCREENING; CLINICAL RESEARCH; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; EXPLORATORY RESEARCH; GYNECOLOGIC CANCER; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MEDLINE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; UNITED STATES; ARTICLE; EPIDEMIOLOGY; EUROPE; EVIDENCE BASED MEDICINE; META ANALYSIS; METHODOLOGY; MULTICENTER STUDY; NEOPLASM; QUALITY CONTROL;

CLINICAL TRIALS; EPIDEMIOLOGIC STUDIES; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; MULTICENTER STUDIES; NEOPLASMS; QUALITY CONTROL; RESEARCH DESIGN; UNITED STATES;

EID: 0038473996     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.147     Document Type: Review

References (11)

1. Sackett DL, Haynes RB: Evidence base of clinical diagnosis: The architecture of diagnostic research. Br Med J 324:539-541, 2002
2. Baumann M, Bentzen SM, Doerr W, et al: The translational research chain: Is it delivering the goods? Int J Radiat Oncol Biol Phys 49:345-351, 2001
3. Arnold K, Vastag B: Medicare to cover routine care costs in clinical trials. J Natl Cancer Inst 92:1032, 2000
4. Nicolucci A, Grilli R, Alexanian AA, et al: Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer: A lost opportunity for meta-analysis. J Am Med Assoc 262:2101-2107, 1989
5. Dickersin K, Manheimer E, Wieland S, et al: Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials. Eval Health Prof 25:38-64, 2002
6. Dickersin K, Scherer R, Lefebvre C: Identifying relevant studies for systematic reviews. Br Med J 309:1286-1291, 1994
7. Manheimer E, Anderson D: Survey of public information about ongoing clinical trials funded by industry: Evaluation of completeness and accessibility. Br Med J 325:528-531, 2002
8. Djulbegovic B, Adams JR, Lyman GH, et al: Evaluation and appraisal of randomized controlled trials in myeloma. Ann Oncol 12:1611-1617, 2001
9. Begg C, Cho M, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. J Am Med Assoc 276:637-639, 1996
10. Tannock IF: Collaborative clinical trials: Quality or quantity? Int J Radiat Oncol Biol Phys 49:339-343, 2001
11. Slevin M, Mossman J, Bowling A, et al: Volunteers or victims: Patients' views of randomised cancer clinical trials. Br J Cancer 71:1270-1274, 1995